Alkermes plc (ALKS)
Company Info
| ISIN | IE00B56GVS15 |
|---|---|
| CUSIP | 00B56GVS1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $4.78B |
|---|---|
| EPS (TTM) | $2.28 |
| PE Ratio | 12.44 |
| PEG Ratio | -1,057.29 |
| Total Revenue (TTM) | $1.13B |
| Gross Profit (TTM) | $923.87M |
| EBITDA (TTM) | $240.76M |
| Year Range | $22.01 - $32.88 |
| Target Price | $34.92 |
| Short % | 16.74% |
| Short Ratio | 13.88 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ALKS vs. VOO, ALKS vs. SPY
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Alkermes plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Alkermes plc had a return of 2.27% year-to-date (YTD) and 1.21% in the last 12 months. Over the past 10 years, Alkermes plc had an annualized return of -3.83%, while the S&P 500 had an annualized return of 11.26%, indicating that Alkermes plc did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 2.27% | 19.50% |
| 1 month | 0.89% | 3.09% |
| 6 months | 9.92% | 10.74% |
| 1 year | 1.21% | 33.68% |
| 5 years (annualized) | 8.96% | 14.10% |
| 10 years (annualized) | -3.83% | 11.26% |
Monthly Returns
The table below presents the monthly returns of ALKS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.49% | 9.76% | -8.82% | -9.35% | -4.65% | 2.99% | 13.36% | 4.14% | -1.62% | 2.27% | |||
| 2023 | 9.61% | -6.63% | 5.42% | 1.28% | 1.33% | 8.19% | -6.45% | -0.31% | -4.04% | -13.64% | -0.21% | 14.91% | 6.16% |
| 2022 | 9.63% | -2.51% | 5.83% | 9.65% | 3.47% | -0.20% | -14.07% | -7.54% | -5.66% | 1.66% | 9.16% | 5.45% | 12.34% |
| 2021 | 5.21% | -9.29% | -1.89% | 17.83% | 3.00% | 8.16% | 5.51% | 20.83% | -1.34% | -1.78% | -27.63% | 6.11% | 16.59% |
| 2020 | -14.66% | 19.70% | -30.81% | -4.92% | 19.33% | 18.64% | -7.21% | -8.16% | 0.18% | -1.93% | 12.37% | 9.26% | -2.21% |
| 2019 | 11.39% | 1.22% | 9.68% | -16.91% | -28.96% | 4.64% | 2.75% | -9.41% | -7.01% | 0.10% | 7.63% | -2.95% | -30.87% |
| 2018 | 4.46% | -0.16% | 1.54% | -23.62% | 6.62% | -12.80% | 6.54% | 2.26% | -5.35% | -3.79% | -10.75% | -19.02% | -46.08% |
| 2017 | -2.64% | 4.42% | 3.54% | -0.43% | -0.84% | 0.36% | -6.14% | -6.67% | 0.12% | -4.09% | 7.24% | 4.67% | -1.53% |
| 2016 | -59.67% | 0.81% | 5.95% | 16.26% | 16.75% | -6.87% | 15.46% | -12.28% | 7.45% | 7.19% | 12.74% | -2.20% | -29.98% |
| 2015 | 23.38% | -2.77% | -13.21% | -9.18% | 10.35% | 5.30% | 8.83% | -14.94% | -1.49% | 22.58% | 2.00% | 8.21% | 35.55% |
| 2014 | 19.72% | -0.02% | -9.41% | 4.92% | -0.97% | 9.87% | -15.04% | 4.61% | -4.16% | 17.91% | 8.84% | 6.43% | 44.02% |
| 2013 | 24.51% | -5.81% | 9.12% | 29.16% | 2.09% | -8.22% | 17.09% | -5.45% | 5.89% | 4.70% | 14.72% | 0.69% | 119.55% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ALKS is 39, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Alkermes plc (ALKS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Alkermes plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alkermes plc was 96.15%, occurring on Jul 11, 2002. The portfolio has not yet recovered.
The current Alkermes plc drawdown is 71.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.15% | Mar 2, 2000 | 591 | Jul 11, 2002 | — | — | — |
| -92.95% | Jan 10, 1992 | 755 | Jan 4, 1995 | 537 | Feb 18, 1997 | 1292 |
| -64.98% | Feb 19, 1997 | 48 | Apr 28, 1997 | 440 | Jan 26, 1999 | 488 |
| -44.58% | Nov 4, 1991 | 18 | Nov 27, 1991 | 24 | Jan 3, 1992 | 42 |
| -28.52% | Mar 22, 1999 | 42 | May 19, 1999 | 57 | Aug 10, 1999 | 99 |
Volatility
Volatility Chart
The current Alkermes plc volatility is 10.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Alkermes plc compared to its peers in the Biotechnology industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for ALKS in comparison to other companies of the Biotechnology industry. Currently, ALKS has a PE value of 12.4. This PE ratio falls in the average range for the industry.
PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for ALKS in comparison to other companies of the Biotechnology industry. Currently, ALKS has a PEG value of -1,057.3. This PEG value is considered to be low compared to the rest of the industry.
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Alkermes plc.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |